Does BIFIDOBACTERIUM LONGUM Cause Hepatic encephalopathy? 28 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Hepatic encephalopathy have been filed in association with BIFIDOBACTERIUM LONGUM. This represents 20.0% of all adverse event reports for BIFIDOBACTERIUM LONGUM.
28
Reports of Hepatic encephalopathy with BIFIDOBACTERIUM LONGUM
20.0%
of all BIFIDOBACTERIUM LONGUM reports
0
Deaths
28
Hospitalizations
How Dangerous Is Hepatic encephalopathy From BIFIDOBACTERIUM LONGUM?
Of the 28 reports, 28 (100.0%) required hospitalization.
Is Hepatic encephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIFIDOBACTERIUM LONGUM. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does BIFIDOBACTERIUM LONGUM Cause?
Off label use (93)
Abdominal pain (58)
Malaise (58)
Anaemia (57)
Chronic sinusitis (57)
Colitis (57)
Constipation (57)
Drug ineffective (57)
Erythema (57)
Female genital tract fistula (57)
What Other Drugs Cause Hepatic encephalopathy?
ACETAMINOPHEN (562)
RIBAVIRIN (512)
LENVATINIB (502)
RIFAXIMIN (462)
SOFOSBUVIR (360)
BEVACIZUMAB (210)
LEDIPASVIR\SOFOSBUVIR (180)
ATEZOLIZUMAB (178)
SORAFENIB (169)
DACLATASVIR (165)
Which BIFIDOBACTERIUM LONGUM Alternatives Have Lower Hepatic encephalopathy Risk?
BIFIDOBACTERIUM LONGUM vs BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS
BIFIDOBACTERIUM LONGUM vs BILASTINE
BIFIDOBACTERIUM LONGUM vs BIMATOPROST
BIFIDOBACTERIUM LONGUM vs BIMATOPROST\TIMOLOL
BIFIDOBACTERIUM LONGUM vs BIMEKIZUMAB